Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors

BACKGROUND: There are conflicting data on the effects of dysbiosis-inducing drugs, and especially antibiotics (ATBs), on clinical outcomes in patients treated with immune checkpoint inhibitors (ICIs). There is a particular lack of data for patients with melanoma. METHODS: We performed a single-cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaucher, Louis, Adda, Leslie, Séjourné, Alice, Joachim, Camille, Guillaume, Chaby, Poulet, Claire, Liabeuf, Sophie, Gras-Champel, Valérie, Masmoudi, Kamel, Houessinon, Aline, Bennis, Youssef, Batteux, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968039/
https://www.ncbi.nlm.nih.gov/pubmed/33796151
http://dx.doi.org/10.1177/17588359211000591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968039/
https://www.ncbi.nlm.nih.gov/pubmed/33796151
http://dx.doi.org/10.1177/17588359211000591

Ejemplares similares